ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $147,000 | -1.3% | 101,122 | -3.9% | 0.00% | – |
| Q4 2016 | $149,000 | -11.8% | 105,200 | +9.3% | 0.00% | – |
| Q3 2016 | $169,000 | -69.0% | 96,214 | -66.4% | 0.00% | -100.0% |
| Q4 2015 | $545,000 | -64.0% | 286,679 | -63.8% | 0.00% | 0.0% |
| Q3 2015 | $1,513,000 | +641.7% | 791,943 | +1702.1% | 0.00% | – |
| Q2 2015 | $204,000 | -80.4% | 43,946 | -81.5% | 0.00% | -100.0% |
| Q1 2015 | $1,041,000 | -3.8% | 238,166 | -23.6% | 0.00% | 0.0% |
| Q4 2014 | $1,082,000 | +96.7% | 311,874 | +137.7% | 0.00% | 0.0% |
| Q3 2014 | $550,000 | -1.4% | 131,204 | +37.7% | 0.00% | 0.0% |
| Q2 2014 | $558,000 | +2.0% | 95,283 | +9.8% | 0.00% | 0.0% |
| Q1 2014 | $547,000 | -69.9% | 86,788 | -72.1% | 0.00% | -50.0% |
| Q4 2013 | $1,819,000 | -8.1% | 311,021 | -17.2% | 0.00% | -33.3% |
| Q3 2013 | $1,980,000 | -72.8% | 375,781 | -60.3% | 0.00% | -76.9% |
| Q2 2013 | $7,288,000 | – | 946,512 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |